(Q43854654)

English

Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model

scientific article published in October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model (English)

1 reference

Europe PubMed Central

27 November 2017

author name string

Mi Suk Kim

1

1 reference

Europe PubMed Central

27 November 2017

Jeong-Im Sin

2

1 reference

Europe PubMed Central

27 November 2017

publication date

1 October 2005

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

116

1 reference

Europe PubMed Central

27 November 2017

2

1 reference

Europe PubMed Central

27 November 2017

255-266

1 reference

Europe PubMed Central

27 November 2017

Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein D plasmid constructs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA Immunization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Human papillomavirus type 16 and 18 gene expression in cervical neoplasias

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02219.X

21 January 2018

Enhancement of DNA vaccine potency by coadministration of a tumor antigen gene and DNA encoding serine protease inhibitor-6.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

Induction of specific CD8+ T-lymphocyte responses using a human papillomavirus-16 E6/E7 fusion protein and autologous dendritic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

The motif Tyr-X-X-hydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

Human papillomavirus 16 E7 protein is associated with the nuclear matrix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

Human papillomaviruses in the pathogenesis of anogenital cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1817814

3 November 2018

T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16162274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16162274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16162274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16162274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product

1 reference

https://pubmed.ncbi.nlm.nih.gov/16162274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Therapy Modality Using Recombinant IL-12 Adenovirus plus E7 Protein in a Human Papillomavirus 16 E6/E7-Associated Cervical Cancer Animal Model

1 reference

https://pubmed.ncbi.nlm.nih.gov/16162274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2567.2005.02219.X

1 reference

Europe PubMed Central

27 November 2017

0 references

1 reference

Europe PubMed Central

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43854654&oldid=2103911837"